Synovium-derived stem cell-based meniscal reconstruction on small intestinal submucosa by Tan, Yunbing
Graduate Theses, Dissertations, and Problem Reports 
2009 
Synovium-derived stem cell-based meniscal reconstruction on 
small intestinal submucosa 
Yunbing Tan 
West Virginia University 
Follow this and additional works at: https://researchrepository.wvu.edu/etd 
Recommended Citation 
Tan, Yunbing, "Synovium-derived stem cell-based meniscal reconstruction on small intestinal submucosa" 
(2009). Graduate Theses, Dissertations, and Problem Reports. 4542. 
https://researchrepository.wvu.edu/etd/4542 
This Thesis is protected by copyright and/or related rights. It has been brought to you by the The Research 
Repository @ WVU with permission from the rights-holder(s). You are free to use this Thesis in any way that is 
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain 
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license 
in the record and/ or on the work itself. This Thesis has been accepted for inclusion in WVU Graduate Theses, 
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. 
For more information, please contact researchrepository@mail.wvu.edu. 
Synovium-derived Stem Cell-based Meniscal Reconstruction on  
Small Intestinal Submucosa 
 
 
Yunbing Tan 
 
 
Thesis Submitted to the 
College of Engineering and Mineral Resources 
at West Virginia University 
in Partial Fulfillment of the Requirements 
for the Degree of 
 
 
Master of Science 
In 
Mechanical Engineering 
 
 
Ming Pei, M.D., Ph.D., Chair 
Jacky Prucz, Ph.D. 
Nianqiang Wu, Ph.D. 
 
Department of Mechanical & Aerospace Engineering 
 
Morgantown, West Virginia 
2009 
 
Keywords: Meniscus, Synovium-derived stem cells, Co-culture, Small intestinal 
submucosa, Bioreactor, Compressive loading  
Copyright 2009 
ABSTRACT 
 
 
Synovium-derived Stem Cell-based Meniscal Reconstruction on  
Small Intestinal Submucosa 
 
By Yunbing Tan 
 
 
This study was aimed at investigating the feasibility of co-culturing meniscus cells and 
synovium-derived stem cells on small intestinal submucosa (SIS) in order to establish an 
innovative method and further to optimize the culture conditions for engineering in vitro 
meniscus constructs. First, two groups of individual cells and a co-culture group were 
mixed with fibrin gel and seeded onto SIS discs, then incubated in a serum-free defined 
medium for one month. Electron and fluorescent microscopy were utilized to evaluate 
cell attachment and migration. Through histology, biochemical quantification, real time 
PCR, and compressive modulus, the co-culture group showed greater cell viability and 
exhibited higher glycosaminoglycan, collagen II, and Sox9 but relatively low collagen I, 
resulting in the concomitant increase in equilibrium modulus and demonstrating the 
advantages of co-culturing. Based on these results, we utilized rotating bioreactors and 
compressive loading for co-culture constructs to improve their function. However, the 
results were unsatisfactory; we carefully analyzed the reasons and made useful 
suggestions for future studies. 
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CHAPTER 1 INTRODUCTION 
 
Meniscus is a crescent-shaped fibrocartilaginous structure present at the peripheral aspect 
of joints. The knee menisci are concave on the top and flat on the bottom, articulating 
with the tibia. They have several important functions in joint stability, lubrication, 
nutrition, and shock absorption. As secondary stabilizers, the intact menisci interact with 
the stabilizing function of ligaments and are most effective when the surrounding 
ligaments are intact. They serve to disperse the weight of the body and to reduce friction 
in the knee joint between the lower leg (tibia) and the thigh (femur). 
 
Two common causes of a meniscal tear are traumatic injury and degenerative processes. 
The former is often seen in athletes and the latter is seen in older patients who have more 
brittle meniscus. The meniscus tear often occurs along with injuries to the anterior 
cruciate ligament (ACL) and the medial collateral ligament (MCL). The symptoms of 
meniscus tear include knee pain, swelling of the knee, tenderness when pressing on the 
meniscus, popping or clicking within the knee, and limited motion of the knee joint. 
Injury or loss of meniscus can lead to osteoarthritis and irreversible joint damage1. 
 
Treatment options for torn menisci vary according to the region of the lesion. The 
meniscus is vascularized only in the outer third and lesions occurring in the inner two-
thirds rarely heal spontaneously. Partial or total removal of the torn meniscus was a 
standard therapy in the past. However, because of the change in contact pressure and 
contact area2, meniscectomy has been strongly associated with the development of early 
osteoarthritis 3 . Experimental studies using meniscus prostheses have yielded 
unsatisfactory results 4 . Problems with biocompatibility, wear, and inferior material 
properties of these prostheses have led investigators to pursue a more biological approach 
through the creation of a tissue-engineered meniscus. 
 
Tissue engineering is the use of a combination of cells, engineering and materials 
methods, and suitable biochemical and physio-chemical factors to improve or replace 
biological functions. It is closely associated with applications that repair or replace 
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portions of or whole tissues, including bone, cartilage, blood vessels, and bladder. In 
tissue engineering techniques, many fundamental biological factors should be addressed, 
including cell source, matrix scaffold, bioreactor design, and environmental conditions5. 
Currently there are few tissue-engineering techniques that can regenerate satisfactory 
meniscus tissues. In order to develop a novel treatment of meniscus tears and defects, we 
selected a combination of cells, scaffold, medium, growth factors, culturing conditions, 
and mechanical stimulation based on literature review. We will conduct experiments to 
test our creative technique. 
 
The objective of this work will be to develop an innovative and effective tissue 
engineering technique for the treatment of meniscus tears and defects. To test this overall 
objective, supporting objectives have been identified. 
 
1. Test the biocompatibility of the scaffold with the cells we use, which means 
whether the cells are viable on the given scaffold.  
2. Make sure the scaffold will not generate a negative influence on the 
proliferation of cells on it.  
3. Test and compare the biochemical features of the constructs we obtain with 
natural meniscus tissues, which is a key point to cure meniscal degeneration or 
trauma.  
4. Test the mechanical properties of the constructs to better validate this technique. 
5. Study the effects of rotating bioreactor culture on the meniscal constructs. 
6. Study the effects of compressive stimulation on the meniscal constructs. 
 
The overall design of my study can be summarized as shown in Figure 1 on the next page. 
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Figure 1 Overall design for this study 
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CHAPTER 2 LITERATURE REVIEW 
 
2.1 Meniscus Physiology 
2.1.1 Anatomic Structure 
The menisci are paired semilunar (C-shaped) fibrocartilage structures that are located 
between the femoral condyles and the tibial plateau. As shown in Figure 2, they are 
wedge-shaped with convex outer margin much thicker than the inner margin. The 
proximal (or femoral) surface is concave, whereas the distal (or tibial) surface is flat to 
convex6. 
 
 
Figure 2 Human meniscus (shown attached to tibia)7 
 
The menisci are approximately 35 mm in diameter8 and feature a firm connective tissue 
attachment to the joint capsule at their outer margin, which usually measures 
approximately 110 mm in circumference9. The anterior and posterior horns of each 
meniscus are anchored to bone via insertional ligaments. The transverse ligament 
connects the anterior horns of the medial and lateral menisci and has fibers blending in 
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with the tibial insertion of the anterior ACL. The medial meniscus is larger than the 
lateral meniscus in the anteroposterior plane, and both menisci are narrower at the 
anterior horns and become wider posteriorly. The lateral meniscus is more uniform in 
width throughout its course (Figure 3). Collagen fibers running along the circumference 
of the meniscus continue into the anterior and posterior insertional ligaments, which 
anchor the meniscal horns via interdigitations with subchondral bone through uncalcified 
and calcified fibrocartilage10. 
 
 
Figure 3 Anatomy of the menisci viewed from above11 
 
The most common anatomic variation of the menisci is the discoid meniscus. More 
common laterally (with an incidence of 1.5% to 16.6%)12, it appears as a thickened 
wafer-shaped structure. Medial and bilateral cases of discoid structure have been reported. 
The Watanabe13 classification describes three variations of a discoid lateral meniscus: (1) 
an incomplete type, featuring a larger than normal meniscus but with normal attachments; 
(2) a complete type with a full disk covering the entire tibial plateau; and (3) a Wrisberg 
type, with no meniscal attachments to the posterior tibia or joint capsule but with a 
normal attachment to the Wrisberg ligament. Currently, discoid menisci are thought to be 
a cognetial phenomenon with some evidence of familial transmission14. 
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From an anatomic standpoint, one of the most crucial features of the meniscus is its 
vasculature. The meniscal blood supply (or lack thereof in the central regions) has 
profound implications for the healing of meniscal repairs. The lateral, medial, and middle 
geniculate arteries provide the primary blood supply to the menisci, forming a 
parameniscal capillary plexus embedded within the capsular and synovial tissues15. This 
parameniscal capillary plexus is located along the entire peripheral border of both 
menisci and features vessels that are oriented circumferentially, with radial branches 
directed at the joint center terminating in small capillary loops. Prenatally, blood vessels 
traverse the entire body of the meniscus with the highest density in the peripheral third. 
Postnatally, a gradual decrease in vascularity of the inner two thirds occurs, along with a 
decrease in cellularity and an increase in collagen content. The postnatal decrease is 
thought to be caused by vertical load bearing, which would explain why the non-weight-
bearing meniscal horns retain a rich blood supply throughout adult life. In the adult 
meniscus, capillary loops penetrate no deeper than 10% to 25% of the width of the lateral 
meniscus and 10% to 30% of the medial meniscus. In addition, the posterolateral region 
of the lateral meniscus has an avascular area surrounding the popliteal tendon. 
 
The anterior and posterior horns of the menisci are covered by a vascular synovial tissue 
that is continuous with the synovial sheath of the cruciate ligaments and is found along 
the periphery of the entire meniscus, extending over a small portion of both the superior 
and inferior surfaces. These layers do not contribute to the blood supply of the noninjured 
meniscus, but can play an important role in meniscal healing if stimulated by injury or 
repair. Rasping or abrading these tissues can stimulate vascular overgrowth onto the 
meniscus; the synovium contains pluripotential mesenchymal cells that may play a role in 
meniscal repair. 
 
2.1.2 Biochemical Composition 
The composition of the adult meniscus is 70% water; 75% of its dry weight is collagen, 
8% to 13% is noncollagenous protein, and 1% is hexosamine16. The proteoglycan portion 
of the meniscus, including chondroitin 6-sulfate (40%), chondroitin 4-sulfate (10% to 
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20%), dermatan sulfate (20% to 30%), and keratin sulfate (15%)17, accounts for less than 
1% of its dry weight and is located primarily in the inner region of the meniscus, with 
little in the periphery where thick collagen fibers are aligned18. The compositions of 
meniscus by region are summarized in Table 1. 
 
Table 1 Compositions of meniscus by region19 
Region n 
Sulfated Glycosaminoglycan 
(% dry weight) 
Water Content 
Hydroxyproline 
(% dry weight) 
LA 18 1.80±0.50 75.02±2.14 14.3±3.7 
LC 18 1.68±0.56 72.99±2.40 13.2±2.0 
LP 18 1.75±0.45 73.39±2.44 15.2±3.1 
MA 12 2.20±1.01 72.12±9.73 13.2±3.6 
MC 14 2.06±0.68 76.77±2.68 13.9±3.4 
MP 18 1.94±0.83 74.88±7.32 13.9±3.6 
 
LA = lateral anterior, LC = lateral central, LP = lateral posterior, MA = medial anterior, 
MC = medial central, MP = medial posterior. 
 
 
Collagen types I, II, III, V, and VI have been found within meniscal tissue, which account 
for 60-70% of the dry weight6. Type I collagen is by far the most predominant, 
accounting for >90% of the collagen within the tissue20. A study done by Cheung21 
showed that in bovine menisci, the outer two-thirds of the menisci is predominantly type 
I collagen, whereas the inner one-third is 60% type II collagen and 40% type I collagen. 
He also found that the concentration of collagen was greater in the outer section, 80.1% 
dry weight vs. 69.3% dry weight21. The meniscus has a unique collagen structure 
orientation that is related to its function and consists of three different layers (Figure 4). 
The superficial layer consists of a thin layer of randomly oriented fibers22. The lamellar 
layer, located just inside the superficial layer, also consists of randomly oriented fibers, 
with the exception of the peripheral portions at the anterior and posterior sections; here 
the fibers are oriented radially22. The deep zone consists of circumferentially oriented 
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fibers with a small amount of radially oriented fibers, also referred to as tie fibers. It has 
also been shown that the amount of collagen synthesized by the fibrochondrocytes 
decreases with age23. 
 
 
Figure 4 Meniscus collagen structure7 
 
Proteoglycans, with large size and anionic charge, endow the menisci with strong shock-
absorption properties. This composite acts like a large sponge because of its water 
retention properties. The proteoglycan and collagen content of the meniscus increases 
with age until maturity and then remains relatively constant, in marked contrast to 
articular cartilage, which features a steady decline in proteoglycan content with age24. 
The ratio of chondroitin 6-sulfate to chondroitin 4-sulfate increases with age while the 
water content increases significantly because of the accumulation of water-binding 
proteoglycans in degenerated menisci. Degenerated menisci from knees with 
osteoarthritis and rheumatoid arthritis contain less collagen, more non-collagenous matrix 
protein and hexosamine25, and more water; this is attributable to a disrupted collagen 
network that is unable to resist swelling pressure from the proteoglycans in tissue26. 
Adams and associates26 also found that meniscal glycosaminoglycans were decreased 
early on in inflammatory arthritis. 
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2.1.3 Function and Behavior 
Functionally, the meniscus is a shock absorber, helps with load bearing and transmission 
in the knee joint, improves stability in the knee, and helps with lubrication. Because of all 
these different functions and the geometry of the tissue, the meniscus is subjected to 
compressive, tensile, and shear stress (Figure 5). 
 
Figure 5 Free body diagram of the meniscus7 
 
One of the first proposed functions of the meniscus was load transmission. Subsequent in 
vitro studies have confirmed this role and demonstrated that 70% of the load in the lateral 
compartment and 50% of the load in the medial compartment is transmitted through the 
menisci2. Ahmed and Burke showed that over 50% of compressive load is transmitted 
through the posterior horns in extension, with 85% transmission at 90º of flexion. The 
ability of the meniscus to effectively dissipate loads across the tibial plateau results from 
the fact that the shape of the menisci bridges the incongruence between the relatively 
spherical femoral condyles and the flat tibial plateau. The meniscus increased the contact 
area, which allows a decrease in pressure across the central portion of each compartment. 
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Fukubayashi and Kurosawa27 reported that the femoral-tibial contact area of the knee is 
1,150 mm2 with menisci and 520 mm2 without menisci; accordingly, the peak pressures 
were recorded across the knee joint at 3 MPa with menisci and 6 MPa without. 
 
Closely related to the load transmission role of menisci is their role in shock absorption. 
When a sudden load is applied across the knee joint, an intact meniscus can dissipate 
forces because of its biphasic structure. The solid phase (proteoglycan and collagen) and 
liquid phase (water) function under compression similar to articular cartilage. 
Additionally, the unique architecture of the meniscus allows the conversion of vertical 
forces into tangential and radial forces as the meniscus moves peripherally under load. 
This conversion is made possible by the circumferential orientation of collagen fibers in 
the body of the meniscus, with firm attachments at the anterior and posterior horn to tibia. 
Vertical joint loading causes tension and elongation of these circumferential fibers, 
effectively converting the vertical load into horizontal “hoop stresses” in the intact 
meniscus. In an intact meniscus, the compression force at the meniscotibial surface is 
smaller than that at the meniscofemoral surface28. This dissipation of forces is dependent 
on the intact circumferential orientation of collagen fibers in the meniscus. In the 
meniscus, most fibers are circumferentially oriented; thus its greatest tensile strength is 
circumferential29. This shock-absorbing function is dependent on the strong collagenous 
attachments of the insertional ligaments to bone. Messner and Gao30 have emphasized the 
transition from ligament to bone through uncalcified cartilage and calcified cartilage as 
an effective anchor when stressed by a compressive load. Consistent with studies 
showing the increased load-bearing function of the lateral meniscus, there is more 
calcified tissue in the insertional ligaments of the lateral anterior and posterior horns of 
the meniscus30. 
 
The meniscus also plays an important role in maintaining joint congruity and stability. 
The menisci serve to create a socket, which improves the articulation between the 
disparate shapes of the femoral condyles and tibial plateau. When this meniscal socket is 
intact, axial loading of the knee has a multidirectional stabilizing function, limiting 
excess motion in all directions. Markolf and associates31, 32 have addressed the effect of 
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meniscectomy on anterior-posterior and rotational knee laxity. With medial 
meniscectomy alone, anterior-posterior tibial translation at 90º of flexion increased to 
1.82 times the baseline; valgus-varus laxity also increased in flextion, to 1.36 times the 
baseline. 
 
2.2 Meniscal Injuries 
In order for the meniscus to provide these protective functions, structural continuity must 
be maintained throughout the entire meniscus from the anterior to posterior insertional 
ligaments. If a tear of the meniscus or either of the insertional ligaments disrupts this 
continuity, then the load transmission system breaks down. Hoop stresses cannot be 
maintained and the result is a functional meniscectomy. Fortunately, a partial-thickness 
tear may still allow some degree of function depending on the size and direction of the 
tear. Partial meniscectomy is always preferable to total excision as long as some 
circumferential fibers remain intact33. Experimental evidence suggests that the loss of a 
meniscus results in at least 20% reduction of this shock-absorbing function34. 
 
In the United States, meniscal injuries may be the most common knee injury. The 
prevalence of acute meniscal tears is 61 cases per 100,000 persons. The overall male-to-
female incidence is approximately 2.5:1. The peak incidence of meniscal injury for males 
is in those aged 31-40 years. For females, the peak incidence is in those aged 11-20 years. 
In patients older than 65 years, the rate of degenerative meniscal tears is 60%. Surgical 
procedures of the meniscus are performed on an estimated 850,000 patients each year35. 
Estimates indicate that at least twice this number of meniscus procedures are performed 
worldwide. 
 
The two menisci are easily injured by the force of rotating the knee while bearing 
weight36. A partial or total tear of a meniscus may occur when a person quickly twists or 
rotates the upper leg while the foot stays still (for example, when dribbling a basketball 
around an opponent or turning to hit a tennis ball). If the tear is tiny, the meniscus stays 
connected to the front and back of the knee; if the tear is large, the meniscus may be left 
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hanging by a thread of cartilage. The seriousness of a tear depends on its location and 
extent. 
 
Injuries to the meniscus usually consist of tears in the tissue, although separation from the 
tibial attachments and degeneration of the tissue also occur37, 38. Different styles of tears 
can occur, such as longitudinal and bucket-handle tears (most common), radial tears, and 
complex tears. In 1936, King37 was the first to show that tears in the vascularized portion 
of the meniscus would naturally heal, whereas tears in the avascular portion would not. It 
has also been shown that longitudinal tears, if they heal, restore native mechanical 
function, but radial tears, where the collagen structure is disrupted, do not have restored 
mechanical function after healing.  
 
In the case of older, degenerated menisci that typically split apart or break down under 
routine, day-to-day or minimal stress conditions, the meniscus itself has not been healthy 
for some time. A degenerative meniscal defect will almost never bleed, and in fact may 
often occur gradually, without the patient even being aware of it. When such gradual, 
degenerative meniscal cleavage or fissuring develops and is discovered by MRI scanning 
or arthroscopy, while it is still commonly said that the patient “tore” their meniscus, this 
is actually a mischaracterization. To most people, “tearing” something implies a sudden 
structural failure in response to a specific, applied force. While the terms “torn” and 
“tear” are convenient for surgeons to use because they are familiar to patients, it is 
misleading to use them in relation to a degenerated meniscus that is simply worn, frayed, 
fissured, fragmented or just plain broken down.  
 
2.3 Classical Treatments 
Meniscectomy, or removal of the meniscus, is the dominant repair technique attempted 
for meniscus defects. Due to the poor long-term results of meniscectomy, efforts have 
also been made to seal tears that occur in meniscus and replacement of the meniscus. 
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2.3.1 Meniscectomy 
The menisci were originally thought to have little importance in knee function and were 
believed to be functionless remains of leg muscle39. These beliefs led to the practice of 
removing the meniscus whenever there was a complication. In the 1930s, King37 showed 
that degenerative effects in the articular cartilage are a side effect of meniscectomy, and 
widespread attention to this complication occurred after a series of studies in the 1960s 
and 1970s39. Directly after removal of the meniscus, the mechanical function of the knee 
joint alters, leading to greater stress applied to the articular cartilage40, 41. Over time, a 
new tissue is grown by the body to fill the defect, and the cellular distribution within the 
tissue shows discrepancy42. Partial meniscectomy, which is removal of a small portion of 
the meniscus, usually in the avascular zone, has been shown to cause fewer degenerative 
changes in the articular cartilage than a full meniscectomy43. A partial meniscectomy has 
the advantage of leaving the majority of the collagen structure of the meniscus in the 
knee, allowing the partial meniscus to still absorb some of the shock43. After a partial 
meniscectomy, a fibrin clot forms in the area of the removed tissue, which then acts as a 
scaffold for cellular ingrowth, though this does not always occur44. McDermott and Amis 
reviewed the consequences of total and partial meniscectomy and summarized the body 
of evidence in the literature regarding those factors most relevant to long-term outcome45. 
 
2.3.2 Repair of Meniscal Tears 
After the realization that meniscectomy causes degeneration of articular cartilage, the 
healing method of choice started to be repair of the meniscal tear. A variety of different 
methods have been tried: suture, meniscal arrows, fibrin sealant, laser welding, and 
abrasion therapy46, 47, 48, 49. Sutures are used to reconnect the torn tissue until it heals 
together. There are several different suturing methods that have been attempted, the goal 
being to increase the strength of the wound site47, 50. Meniscal arrows are biodegradable 
devices that are marketed to replace sutures because they are easier to use51. Fibrin 
sealant and laser welding tests have been done to test their effectiveness in sealing tears; 
in general, they are inferior to suture but can be used in conjunction with suture for better 
results46. Abrasion therapy, which roughens up the tissue surrounding the tear and 
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removes necrotic tissue, will usually also be used to aid the healing process48. Suture, 
meniscal arrows, fibrin sealant, and laser welding are all techniques that can be used 
alone to help healing in the vascularized zone. 
 
2.3.3 Meniscal Replacement 
Meniscal allograft research has been rather extensive, and the results seem to be 
promising, though there are no long-term data52. The effects of different preservation 
techniques and attachment methods have been tested. Studies showed that there were few 
differences between cryopreserved and deep-frozen meniscal tissue in the goat model at 1 
year53. The deep-frozen technique kills all of the cells, leaving the allograft to act as a 
scaffold, whereas the cryopreservation technique leaves 10-30% of the fibrochondrocytes 
viable54. Cryopreserved allografts have been shown to hold a higher water content and a 
decreased proteoglycan concentration when compared to native tissue55 . One of the 
difficulties with full meniscal replacement is attachment to the tibial plate. It has been 
shown that bone plugs offer the best mechanical results, but these plugs do not simulate 
the native tissue and long-term results are unknown56, 57. Overall, although meniscal 
transplantation offers the best results for certain meniscal conditions such as radial tears, 
complex tears, and degenerative tissue, the current research shows that degeneration of 
the articular cartilage still occurs and a better alternative needs to be developed. 
 
Different types of meniscal prostheses, including collagen, permanent synthetic scaffolds, 
and biodegradable scaffolds, have been used in experimental and clinical studies. Several 
materials have been tried, such as poly(tetrafluoroethylene) (PTFE), Dacron, and 
polyurethane-coated versions of the previous two materials 58 , 59 . Although the 
polyurethane-coated PTFE gave the best results, the prosthesis was still mechanically 
inferior to native meniscal tissue58. Tissue engineering of the meniscus seems to be the 
preferred method for healing the meniscus. van Tienen60 highlighted the research on 
these meniscal substitutes and showed that current research is mainly focused on a 
biological tissue-engineering approach either with or without additional cell-seeding 
techniques. 
 15
 
2.4 Treatment via Tissue Engineering 
When compared to other musculoskeletal tissues such as bone or articular cartilage, the 
number is relatively smaller for the studies done in the attempt to tissue engineer 
meniscus. A large amount of work has been done on a variety of cells and scaffold 
materials. Knowledge on how fibrochondrocytes react to a variety of growth factors has 
been discovered through a variety of tests from tissue engineering studies. Some studies 
have been done on culturing conditions for fibrochondrocytes, but there is still plenty of 
room for development. Mechanical stimuli were increasingly studied in the area of tissue 
engineering, especially for musculoskeletal tissues including meniscus. The complex 
nature of the cells and extracellular matrix make the meniscus a difficult tissue to 
engineer successfully. Many fundamental biological factors about this technique require 
attention, including cell source, matrix scaffold, growth factors, culturing conditions, and 
mechanical stimuli 5. The overall strategy for meniscal tissue engineering is shown in 
Figure 6. 
 
2.4.1 Cell Sources 
Meniscus cells (MCs) and mesenchymal stem cells (MSCs) have been proposed as 
potential cell sources contributing to the healing and remodeling response of the 
meniscus in vascular and avascular regions61. MCs, especially in the inner third of 
meniscus, are mostly fibrochondrocytes, where 60% of collagen is type II and five to six 
times more glycosaminoglycan (GAG) is present compared with the outer third 21, 62. 
However, the proliferative capacity of fully differentiated adult cells is limited and long-
term in vitro expansion can reduce their functional quality. An MSC is a pluripotent cell 
that divides many times and its progeny gives rise to skeletal tissues63. Recent studies 
suggest that MSCs may possess unusual immunologic properties that may permit allo- 
and xenotransplantation64. MSC differentiation requiring more complex cues may be 
provided by culturing the multipotent cells with more differentiated cells, which guide 
MSCs toward determined differentiation65. Bone marrow stem cells (BMSCs), a popular 
MSC, have been investigated for their ability to contribute to meniscus reconstruction in 
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animal models but the results are mixed66, 67. Compared to the other sources of MSCs, 
synovium-derived stem cells (SDSCs) have the greatest ability for chondrogenesis  
 
 
Figure 6 Strategy for tissue engineering the knee meniscus7 
 
demonstrating the superiority of synovium as a potential source of MSCs for clinical 
applications in cartilage-like tissue regeneration68, 69. However, to our knowledge, there is 
no study focusing on using SDSCs as the cell source for meniscus tissue engineering. 
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Co-culture, a technique with different cells cultured together, has proved to be a powerful 
tool in tissue engineering, not only to generate tissues and organs consisting of multiple 
cell types but also to guide and support the tissue formation through cellular interactions 
with other cell types70 . In cartilage research, co-culture has been used to study the 
development of osteoarthritis and the homeostasis of the tissue itself71, 72. There were 
studies co-culturing expanded articular chondrocytes with bone marrow mesenchymal 
stem cells, which suggested that co-culture was possibly responsible for the 
differentiation of the expanded chondrocytes in pellets 73 . Meniscus also consists of 
multiple cell types and its structure is complicated74.  
 
2.4.2 Scaffold Materials 
Scaffolds can be separated into two major categories: natural and synthetic. Many natural 
scaffolds have been used for tissue engineering of the meniscus: agarose, collagen, small 
intestinal submucosa (SIS), periosteal tissue, and perichondral tissue. A study done by 
Walsh and co-workers75 using periosteal tissue in a rabbit model showed both hyaline 
cartilage and bone growing in the repair tissue at the end of the 24-week trial. The results 
from perichondral tissue were not much better; the 12-month test in sheep showed repair 
tissue that resembled the meniscus grossly, but the tensile modulus of the repair tissue 
was much lower than native menisci 76 . Agarose was studied by Aufderheide and 
Athanasian77, and they found that agarose maintained a lower cell number compared to 
the synthetic scaffold poly(glycolic acid) (PGA). Collagen studies done by Walsh and co-
workers75 and Mueller and co-workers78 yielded encouraging results, but no mechanical 
tests were performed on the repair tissue. SIS, an acellular extracellular matrix (ECM) 
and collagen-based xenogenetic biomaterial, has been shown to induce site-specific 
remodeling of various connective tissues and to promote a reconstructive healing 
response79. Due to minimal immune response80and low risk of disease transmission81, SIS 
has gained approval for clinical implant in the United States, Europe, and Australia. 
Recent studies indicated that SIS has been successfully utilized not only as an unseeded 
form to promote meniscus regeneration82, 83, but also as a seeded scaffold to regenerate 
tissue constructs, such as bladder84, cartilage85, and anterior cruciate ligaments86. A 
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potential clinical problem with the unseeded technique is that unseeded grafts may be 
limited to a finite size of regenerated tissue; this problem may be overcome when SIS is 
used in a cell-seeded form. 
 
There is a series of synthetic scaffolds containing carbon fibers that were attempted, but 
mediocre results halted research into the use of these scaffolds. Veth and co-workers87 
attempted just plain carbon fibers and carbon fibers embedded in a polyurethane-poly(L-
lactide) matrix. The gross results for the short term were promising, however no 
biochemical or biomechanical studies were performed87. They also did a study in which 
they used PLLA fibers instead of carbon fibers; the results were better, but again no 
biochemical or biomechanical tests were performed88. Another group, Wood and co-
workers89, also tried using carbon fibers; their embedding matrix was polyester. Their 
results were mediocre overall, with degeneration of the articular cartilage and little 
ingrowth of tissue occurring.  
 
Another synthetic material, polyurethane, was studied for the tissue engineering of 
meniscus. Polyurethane was first used in an attempt to improve healing in a longitudinal 
tear of a canine’s meniscus90, and it was used to replace the lateral canine meniscus in a 
later study91. They noted better results than what occurred after a meniscectomy, but 
there was still degeneration of the articular cartilage. Another study consisted of a 50-
week canine study where the polyurethane was used to replace a portion of the 
meniscus92. Types I and II collagen were found, however no biomechanical tests were 
performed and degeneration of the articular cartilage was noted. Unfortunately, the 
aromatic polyurethane used in the previous studies releases toxic particles during 
degradation93.  
 
PGA is an alternate synthetic scaffold for meniscal tissue engineering. Aufderheide and 
Athanasian77 found that PGA maintained a higher cell number compared to the agarose 
scaffold. Another group regenerated whole meniscus using meniscal cells and PGA-
derived scaffolds in a rabbit total meniscectomy model 94 . They fabricated a 
biodegradable scaffold in a meniscal shape from PGA fiber mesh that was mechanically 
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reinforced by bonding PGA fibers at cross points with 75:25 poly(lactic-to-glycolic acid). 
However, tissue-engineered meniscus showed some differences in collagen content and 
aggregate modulus in comparison to native meniscus. 
 
2.4.3 Growth Factors 
Numerous growth factors have been used on meniscal fibrochondrocytes to test their 
effects on the healing of tears or defects, or on protein synthesis under tissue or cell 
culture conditions. Most experiments have used cell culture approaches, which consist of 
putting fibrochondrocytes or small tissue explants onto a petri dish or into a flask and 
then checking the proliferative response of the cells or protein synthesis. 
 
One growth factor that has potential is transforming growth factor-β (TGF-β). Studies by 
Tanaka and co-workers23 and Collier and co-workers95 showed that TGF-β increases the 
proteoglycan synthesis of fibrochondrocytes from all different sections of the meniscus in 
a dose-dependent manner. Studies by Spindler and co-workers96 and Bhargava and co-
workers97 tested the effect of human platelet-derived growth factor-AB (PDGF-AB) on 
ovine and bovine cells, respectively. PDGF-AB was also shown to increase DNA 
synthesis by the cells from all three sections. Bhargava and co-workers97 also found DNA 
synthesis increases when hepatocyte growth factor (HGF) or bone-morphogenic protein-2 
(BMP-2) was used. BMP-2 and insulin-like growth factor-I (IGF-I) stimulated the 
migration of fibrochondrocytes from the middle zone by 40-50%. This study also tested 
the effects of two other growth factors: interleukin-1 (IL-1), which stimulated migration 
of cells taken from the peripheral third of the tissue, and epidermal growth factor (EGF), 
which stimulated migration of cells from the inner and outer zones by 40–50%. An 
earlier study by Webber and co-workers98 tested the effect that fibroblastic growth factor 
(FGF) and human platelet lysate (PL) had on proliferation of fibrochondrocytes; both 
were found to stimulate growth. Other growth factors, including hyaluronic acid, 
hyaluronan, and endothelial cell growth factor (ECGF), have been studied in both tear 
healing and defect repair99,100,101,102. 
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More recent studies103,104 compared different growth factors, like TGF-β1, PDGF-AB, 
IGF-I, and bFGF; they showed that TGF-β1, a member of TGF-β group, is the most 
promising one in meniscal tissue engineering. Individual and combined effects of three 
growth factors-TGF-β1, IGF-I, and FGF-2-were evaluated in synovial cells culture with 
serum-free chondrogenic medium. Tthe results showed the highest rate of cell growth 
with the synergistic interaction of TGF-β1 and IGF-I applied simultaneously compared to 
any other individual or combined growth factors studied105,106. 
 
2.4.4 Culturing Conditions 
Fibrochondrocytes have been cultured in monolayer, in alginate beads, in agarose 
suspension, and on different scaffolds, some of which have been mentioned before. 
Collier and co-workers95 showed that cells seeded in monolayer produce smaller 
proteoglycans than cells cultured in alginate beads. Studies by Webber and co-workers107 
have shown that fibrochondrocytes cultured in agarose suspension are capable of 
expressing their differentiated phenotype. Webber and co-workers98, 108 , 109  have also 
done a series of studies that tested the effects of different media on fibrochondrocytes. 
They tested how a media containing either Dulbecco’s modified Eagle’s medium 
(DMEM) or Ham’s F-12 media, both supplemented with fetal bovine serum (FBS), 
affected the cells98; the media containing Ham’s F-12 seemed to cause faster growth of 
the fibrochondrocytes. Webber and co-workers108, 109 also developed a serum-free 
medium; it performs better than the serum-free media available commercially, but still 
does not perform as well as media supplemented with FBS. They also developed an 
organ culture model, which consists of removing a meniscus from a rabbit model, 
creating a defect, filling the defect with a scaffold, and placing the meniscus in media. 
Over time, tissue repair can be monitored. Ibarra and co-workers110 have expanded on 
this organ culture model; the explant was implanted subcutaneously or put on a dynamic 
culture system, which consists of an orbital shaker placed inside of CO2 incubator. Their 
results showed better healing from the subcutaneous procedure. 
 
In recent years, serum-free medium was broadly used in the studies of meniscal or 
articular cartilage tissue engineering. Noth et al.111 treated MSCs with defined serum-free 
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chondrogenic medium and DMEM with 10% FBS in collagen type I hydrogels; they 
found that MSC-gels cultured in serum-free medium exhibited higher expression of 
collagen types II and X. Hoben and Athanasiou112 compared serum-free chondrogenic 
medium 10% FBS medium; their results showed that serum-free medium might enhance 
the tensile modulus. Another study by Bilgen and colleagues 113  showed that FBS 
suppressed TGF-β1-induced chondrogenesis in synoviocyte pellet cultures while 
dexamethasone and dynamic stimuli were beneficial. Also, Koay and 
Athanasiou 114 established serum-free, chemically defined conditions to generate 
fibrocartilage with human embryonic stem cells. 
 
2.4.5 Mechanical Stimuli 
Cells can sense changes in their mechanical environment and promote alternations and 
adaptations in tissue structure and function. Mechanical stimuli regulate such 
fundamental processes as cell division and differentiation and determine tissue form. 
Mechanical loading is clearly pivotal to the development, function and repair of all the 
major elements of the musculoskeletal system, including bone, ligament, tendon, skeletal 
muscle, intervertebral disc and meniscus. The prevailing clinical opinion is that, in 
treating musculoskeletal injuries, the repair tissue should first be protected from loading, 
but then subjected to a carefully-measured regime of loading to promote its remodeling115. 
Movement is even essential for synovial joints to cavitate during development, and it 
greatly accelerates the healing of adult tissues. 
 
Although all parts of the musculoskeletal system can adapt to changes in mechanical load, 
the relationship between structure, function and mechanical demands is perhaps best 
known in bone. Menisci are subject to a complex pattern of compressive, tensile and 
shear loads. The distinctive pattern of orientation of collagen fibers in the menisci of the 
knee joint has been suggested to play a role in enabling the menisci to convert 
compressive load into tensile load, so that the compression on the tibial plateau is 
reduced22. 
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Grodzinsky et al.116 reviewed the cartilage tissue remodeling in response to mechanical 
forces, and focused on the effects of mechanical loading on cartilage and the resulting 
chondrocyte-mediated biosynthesis, remodeling, degradation, and repair of the tissue. 
The effects of compression and tissue shear deformation were compared, and approaches 
to the study of mechanical regulation of gene expression were described. The feasibility 
of using fibroblast-like synoviocytes was studied to engineer meniscal-like fibrocartilage 
and to better understand the mechanosensitivity of fibroblast-like synoviocytes by 
seeding them onto collagen scaffolds exposed to dynamic compressive loads117. However, 
their applied biomechanical stimulus did not appear to induce fibrochondrogenesis in any 
treatment group on the scaffolds they used. Considering the fact that fibrocartilaginous 
tissues experience significant tensile stresses in their normal mechanical environment, 
Vanderploeg and co-workers118 investigated mechanical tension as a means to modulate 
matrix synthesis and cytoskeletal organization in bovine articular chondrocytes and 
meniscal fibrochondrocytes (MFCs). Confocal imaging revealed that all cells initially 
displayed a rounded morphology, but over time MFCs spontaneously developed a three-
dimensional, stellate morphology with numerous projections containing organized 
cytoskeletal filaments. Both the biochemical and morphological results of their study had 
important implications for successfully developing cartilage and fibrocartilage tissue 
replacements and repair strategies. Gene expression levels for extracellular matrix and 
cytoskeletal proteins in disc cells were quantitatively studied by Chen et al.119 in an 
alginate culture system subjected to static unconfined compression (25% compressive 
strain) after different time periods (2, 18 and 30 h). Differences in gene expression were 
observed between anulus fibrosus and nucleus pulposus cells following static 
compression for the matrix proteins studied. Anulus fibrosus cells responded to 
mechanical deformation at the 30-h time point, with increasing gene expression for types 
I and II collagen, aggrecan, biglycan, decorin and lumican. In contrast, nucleus pulposus 
cells were not responsive to mechanical loading with changes in gene expression for 
these matrix proteins at any time. 
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CHAPTER 3 MATERIALS AND METHODS 
 
3.1 Cell Harvest and Isolation 
Random biopsies of the intimal layer of synovial tissue were obtained aseptically from 
the knees of two 3-month-old pigs and pooled together for the study. After temporary 
storage in culture medium at 4°C, the synovial tissue was finely minced and digested at 
37°C on an x-y-z shaker (Clay Adams® Nutator; BD Biosciences, Bedford, MA) for 30 
min in phosphate-buffered saline (PBS) containing 0.1% trypsin (Roche, Indianapolis, 
IN) and then for 2 h in a 0.1% solution of collagenase P (Roche) in alpha modified 
Eagle’s medium (αMEM)/10% fetal bovine serum (FBS). The cell suspension was 
passed through a 70-μm nylon filter, and the cells were collected from the filtrate by 
centrifugation. Cells were cultured for 4 days in αMEM with 10% FBS and 1× PS (100 
U/mL penicillin, 100 μg/mL streptomycin). Non-adherent cells were removed by a PBS 
wash on days 2 and 4, and the remaining adherent cells were used for further study. 
 
For negative isolation of SDSCs from primary cultures of adherent synovial cells 
containing macrophages and fibroblasts106, cells were detached by trypsinization for 1 
min (0.25% trypsin/0.2% EDTA), washed, and suspended in PBS/2% FBS (107 cell/mL). 
The suspension was incubated with 5 × 107/mL Dynabeads® M-450 CD14 containing a 
monoclonal antibody specific for macrophages (Dynal Biotech, Oslo, Norway) for 1 h at 
4°C on an x-y-z shaker. The conjugated cells and the unbound Dynabeads® were 
collected using the Dynal Magnetic Particle Concentrator® (Dynal Biotech), and the 
depleted supernatant with SDSCs was transferred to a second tube. After expansion in 
flasks, passage 3 SDSCs were used for this study. 
 
For the isolation of MCs, meniscus tissue was minced and digested sequentially in 0.05% 
hyaluronidase (Sigma, St. Louis, MO) in PBS for 5 min, 0.2% trypsin (Roche) in PBS for 
30 min, followed by 0.2% collagenase II (300 U/mg, Worthington, Freehold, NJ) in PBS 
overnight on an x-y-z shaker (Clay Adams® Nutator). The cell suspension was passed 
through a 70-μm nylon filter, and the cells were collected from the filtrate by 
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centrifugation. MCs were cultured in high-glcucose (HG) DMEM with 10% FBS and 1× 
PS in a 37oC, 5% CO2 incubator. Passage one MCs were used for this study. 
 
3.2 Labeling of SDSCs 
Negatively isolated SDSCs were suspended at a density of 1 × 106/mL in a serum-free 
culture medium, and mixed with 5 μL of Vybrant DiI cell labeling solution (1:200, 
Invitrogen, Carlsbad, CA) by gentle pipetting. After incubating for 20 min at 37oC, the 
mixture was centrifuged at 1500 rpm for 5 min. The cells were ready for use after being 
washed twice using pre-warmed medium.  
 
3.3 Preparation of SIS 
Intact SIS was prepared according to the method previously described by Badylak et 
al.120. Briefly, after harvest of porcine ilium, the mesenteric tissue was removed. The 
mucosa and lamina propria of the lumenal side, as well as the serosal and external muscle 
layers of the adlumenal side, were mechanically removed by manual stripping. The 
resultant submucosa (approximately 2 mm thick) was irrigated copiously in distilled 
water and disinfected with 0.1% peracetic acid solution. The SIS was frozen at –20oC 
overnight in dishes followed by freeze-drying for 5 h. The dry SIS sheet was punched 
into discs with a diameter of 5 mm and sterilized with ethylene oxide. The SIS discs were 
stored sterile and dry at room temperature prior to use. 
 
3.4 Preparation and Incubation of Cell-Hybrid Scaffold Constructs 
Sterile SIS discs were immersed in 100% ethanol, 70% ethanol, and then PBS (without 
Ca2+ and Mg2+). In a centrifuge tube, 75 μL fibrinogen (100 mg/mL in PBS, from human 
plasma; Sigma), 69 μL PBS with cells [three groups: MCs alone, co-culture of MCs and 
pre-labeled SDSCs (50:50, SM), or pre-labeled SDSCs alone], 3 μL thrombin (0.1 U/μL, 
from human plasma; Sigma), and 3 μL CaCl2 (50 mM) were sequentially added. Then, 10 
μL of the cell-gel mixture was pipetted onto an SIS disc in a Petri dish. This procedure 
resulted in fibrin-SIS composites containing 0.9 × 106 cells per construct. The whole 
process was completed in 3 min. The dish with constructs was transferred into an 
incubator at 37oC for 10 min. Medium was added to cover the constructs. 
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After 1 h, the constructs were transferred into non-tissue-culture-treated 24-well plates, 
and the medium was replaced with a chemically defined medium (HG-DMEM, 40 μg/mL 
proline, 100 nmol/L dexamethasone, 0.1 mmol/L ascorbic acid 2-phosphate, 1× PS, and 
1× ITSTM Premix) supplemented with a differentiative growth factor cocktail [10 ng/mL 
transforming growth factor beta1 (TGF-β1) and 500 ng/mL insulin-like growth factor I 
(IGF-I)] for 30 days. For those to be cultured in bioreactors, the constructs were 
transferred into a rotating bioreactor (RCCS-4; Synthecon, Houston, TX) filled with the 
same medium as previously mentioned. Over the course of in vitro cultivation, the 
bioreactor rotation speed was adjusted so that the growing constructs remained freely 
suspended in the rotating flow. Figure 7 is the picture of bioreactors in the incubator. 
 
 
Figure 7 Bioreactor culture in 37ºC incubator 
 
3.5 Compressive Loading 
The constructs were transferred into custom-designed 6-well plates after a 3 week culture 
in rotating bioreactors or static well plates; they were incubated for 3 more weeks with 
compressive loading. The device was designed and built to apply uniaxial compressive 
displacements to the samples in the plates. We had 2 samples in each well, and they were 
placed evenly on the bottom of plate wells. Smooth, impermeable platens were brought 
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into contact with the samples and to held the medium during incubation. The medium 
was the same as previously defined chondrogenic medium with 10 ng/mL TGF-β1 and 
500 ng/mL IGF-I. A displacement corresponding to 10% compressive strain was applied 
every hour for 8 hours, and the loading frequency was 0.5 Hz. Loading of the constructs 
in compression might give rise to transient stresses and strains that vary non-uniformly 
throughout the sample; however, transient changes in the constructs were minimal or not 
existent for a time greater than 25 min121, 122. 
 
Figure 8 shows the experimental equipments for compressive loading, including the well 
plate under compressive loading during the culture process (left top), the tray of well 
plates (left middle), inside the plate wells and their covers (left bottom), and the console 
for both bioreactor rotation and compressive loading (right). 
 
 
 
 
Figure 8 Compressive loading devices 
Left Top: Six-well plates under compressive loading during culture 
Left Middle: Tray for well plates 
Left Bottom: Well structure and corresponding covers 
Right: Console for bioreactor rotation and compressive loading 
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3.6 Scanning Electron Microscopy 
Representative constructs (n=2) at day 2 were primarily fixed for 2 h at room temperature 
in 2.5% glutaraldehyde (Sigma) in distilled water, washed in distilled water 3 times for 
20 min each time. Secondary fixation was completed in 2% osmium tetroxide (Sigma) in 
distilled water for 2 h at room temperature, followed by the same wash procedure after 
primary fixation. The constructs were then dehydrated consecutively in 25%, 50%, 75%, 
95%, and 100% (twice) ethanol for 10 min each, and then in hexamethyldisilazane 
(HMDS, Sigma) at a ratio of 1:1 with ethanol twice for one hour each time, in HMDS at a 
ratio of 1:2 with ethanol overnight, and in HMDS 3 times for 4 h each time. The 
constructs were freeze-dried for 24 h. Each construct was cut into two halves with gold 
sputter on both sides. The images were recorded by a scanning electron microscope 
(Hitachi, Model S 2400, Brisbane, CA). 
 
3.7 Histology and Immunohistochemistry 
Representative constructs (n = 2) were fixed overnight at 4°C in 4% paraformaldehyde 
(Sigma) in PBS, dehydrated with ethanol, paraffin-embedded, and sectioned to 5 μm. 
Consecutive sections were stained with Safranin O/fast green for sulfated GAG and were 
immunostained with monoclonal antibodies against collagen II (II-II6B3; DSHB, Iowa 
City, IA) and collagen I (Sigma). Immunohistochemical sections were de-paraffinized, 
hydrated, treated with 1% hydrogen peroxide to inhibit endogenous peroxidase, and 
incubated for 30 min with 0.2% testicular hyaluronidase (Sigma) in PBS (pH 5) at 37°C 
followed by another 30 min with 1.5% normal horse serum and 30 min at 37°C with the 
primary antibody, then stained using a kit (Vectastain ABC, Burlingame, CA), followed 
by standardized development in diaminobenzidine (DAB, Invitrogen). The sections were 
counterstained with hematoxylin.  
 
3.8 Biochemical Analysis 
For biochemical analysis, constructs (n = 3) were digested overnight at 60°C with 25 
μg/mL papain in PBE buffer (100 mmol/L phosphate, 10 mmol/L EDTA, pH 6.5) 
containing 10 mmol/L cysteine, by using 400 μL enzyme per sample. To quantify cell 
density, the amount of DNA in the papain digests was measured using the QuantiTTM 
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PicoGreen® dsDNA assay kit (Invitrogen) with a CytoFluor® Series 4000 (Applied 
Biosystems). GAG was measured using dimethylmethylene blue dye and a SpectronicTM 
BioMateTM 3 Spectrophotometer (Thermo Scientific, Milford, MA) with bovine 
chondroitin sulfate as a standard. 
 
3.9 TaqMan® Real Time PCR 
For studies of gene expression, the total RNA was extracted from constructs (n = 3) using 
an RNase-free pestle in TRIzol® reagent (Invitrogen) and RNeasy® Mini Kit (Qiagen, 
Valencia, CA). Sample mRNAs were quantified and 1 μg RNA was used for reverse 
transcription (RT) with a High-Capacity cDNA Archive Kit (Applied Biosystems, Foster 
City, CA). The primers and probes of porcine chondrogenic genes (collagen I, collagen 
II, aggrecan, and Sox9) were customized by Applied Biosystems as part of the Custom 
TaqMan® gene expression assays (Table 2). Eukaryotic 18S RNA (Assay ID 
Hs99999901_s1 ABI) was carried out as the endogenous control gene. Real-time PCR 
was performed with the iCycler iQTM Multi Color RT-PCR Detection System (Bio-Rad 
Laboratories, Hercules, CA). The cycle parameters were 50°C for 2 min, hot start at 95°C 
for 10 min followed by 40 cycles of denaturation at 95°C for 15 s, and annealing and 
extension at 60°C for 1 min. The cycle threshold (Ct) values for 18S RNA and that of 
samples was measured and calculated by computer software (Perkin-Elmer, Wellesley, 
MA). Relative transcript levels were calculated as χ = 2-ΔΔCt, in which ΔΔCt = ΔE - ΔC, 
ΔE = Ctexp - Ct18S, and ΔC = Ctct1 - Ct18S. 
 
3.10 Mechanical Test 
The equilibrium compressive moduli of constructs (n=5) were determined in a uniaxial 
stress relaxation test.  The compressive tests were conducted utilizing a stepper motor-
driven miniature compression device manufactured in-house that utilized a 5-mm gage 
length DVRT (Mirostrain, Burlington, VT) for displacement read out and a 50-gram load 
cell (Entran, Fairfield, NJ) to monitor the load as in our previous studies123. In brief, discs 
were equilibrated in PBS containing protease inhibitors then placed in the reservoir on 
the testing machine. The porous movable platen was advanced until a tare load of 
0.00001 Newton was detected. Then a 5% strain step was applied to seat the scaffold 
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Table 2 TaqMan® customized porcine gene primers and probes 
Gene Primer/Probe Sequence (5'-3') Genebank Accession PCR product (bp)
Aggrecan Forward GCCACTGTTACCGCCACTT X60107 58 
 Reverse CACTGGCTCTCTGCATCCA   
  Probe CTGACCGGGCGACCTG   
Col I α1 Forward CCGTGCCCTGCCAGATC AF201723 78 
 Reverse CAGTTCTTGATTTCGTCGCAGATC   
 Probe TCGCACAACACATTGC    
Col II α1 Forward TCCTGGCCTCGTGGGT AF201724 65 
 Reverse GGGATCCGGGAGAGCCA   
  Probe CTCCCCTGGGAAACC    
Col X α1 Forward GGCCCGGCAGGTCATC NM_001005153 80 
 Reverse TGGGATGCCTTTTGGTCCTT   
 Probe TCAGACCTGGTTCCCC    
Sox9 Forward TGGCAAGGCTGACCTGAAG AF029696 96 
 Reverse GCTCAGCTCGCCGATGT   
  Probe CCCCATCGACTTCCGC     
 
evenly in the fixture. After this strain was applied the load was allowed to equilibrate, 
then four consecutive 2% strain steps were applied and each allowed to stress relax. The 
test specimen was unloaded and left for ten minutes to return to its original stress state. 
Once again the porous platen was advanced until a 0.00001 Newton preload was seen 
then a 20% strain step was commanded. From this test the Young’s modulus and stiffness 
was calculated.  
 
The tensile tests were performed in another application specific device that utilized a 
stepper motor as the prime mover and the above-mentioned load cell. The 5 mm diameter 
constructs were visualized under a binocular scope and two parallel cuts were made to 
yield a rectangular shape for tensile testing. The rectangular specimen thickness was 
measured with a vernier caliper and recorded for later use. The specimen was clamped 
between the two grips of the tensile tester and the geometry of the specimen was 
measured with a model 308A video caliper (Colorado Video, Boulder, CO). Small 
reference points were applied to the specimen away from the gripped ends to minimize 
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the effects of the non-uniform stress field. The small load imposed on the specimen from 
gripping was tared out and the video caliper measured the gage length between the two 
reference points at the start. For the tensile equilibrium modulus test, the hydration was 
supplied via irrigation with PBS containing protease inhibitors. Five consecutive 2% 
strain steps were applied and the load was monitored until the rate change of 0.006 MPa 
over one minute was noted. After this test, the specimen was unloaded, kept hydrated and 
allowed to rest for ten minutes to recover to its unstressed state. To obtain the Young’s 
modulus and stiffness, a single stretch test was performed. A 25% strain step was 
commanded and the load verses displacement curve was recorded using a data acquisition 
card das-16 (Measurement Computing, Middleboro, MA) housed in a Dell laptop with 
Labtech Notebook software (Labtech , Wilmington, MA).  
 
The four or five consecutive 2% strains and corresponding stresses were plotted, and 
regression analysis was made and the slope was calculated as the equilibrium modulus. 
For Young’s modulus and stiffness, the one step of 20% or 25% strain and corresponding 
stress was used, and the ratio of stress to strain was considered as the value of Young’s 
modulus. Combining the geometrical parameters of constructs, including cross-sectional 
area and thickness or length, we calculated the stiffness using the formula 
 
where k is the stiffness, A is the cross-sectional area, E is the Young's modulus, L is the 
length of construct.  
 
3.11 Statistics 
We used a one-way ANOVA F test to compare the differences in biochemical analyses (n 
= 3 for each group), and compressive modulus (n = 5 for each group) between the groups. 
Statistical analysis was performed with SPSS 13.0 statistical software (SPSS Inc., 
Chicago, IL). Post-hoc power analyses were performed using a significance level of 0.05 
and a minimum power equal to 0.80, assuming a two-sided alternate hypothesis. 
Estimates of standard deviation were obtained from the observed samples. 
 
 31
CHAPTER 4 EXPERIMENTAL RESULTS 
 
4.1 Results from Part I 
4.1.1 Microscopic Observation 
SEM was used to evaluate the morphology of SIS and adhesion of cells on SIS scaffolds. 
Figure 9A shows the rough serosal side of SIS while Figure 9C displays the smooth 
mucosal side of SIS. After saturation with fibrin gel, both sides became more wrinkled 
(Figure 9B versus 9A, Figure 9D versus 9C). One day after cells were seeded with fibrin 
gel on SIS scaffolds, the scaffold profile exhibited several layers after freeze-drying 
(Figure 10A); high magnification showed that the cells were round and evenly distributed 
(Figure 10B) and some cells were distributed in scaffold wrinkles (Figure 10C) and holes 
(Figure 10D). Cells of all three groups exist almost everywhere and at a high density on 
the surface of SIS. Moreover, cells on the surface potentially interact with each other and 
with the SIS surface according to the higher magnified images, which tells us that SIS, a 
natural biomaterial, may be a biocompatible material for meniscus tissue engineering.  
 
To trace cell migration and distribution on SIS, SDSCs were pre-labeled with Vybrant 
DiI (red color) and DAPI was used to counterstain nuclei (blue color) for both SDSCs 
and MCs. At day 0 after cell seeding, only blue was seen in the MC group (Figure 11a0) 
and mixed colors were shown in the SDSC group (Figure 11c0). In contrast, both the 
mixed colors and isolated blue were seen in the SM group (Figure 11b0). The 
corresponding light microscope images (Figure 11A0, 11C0, 11B0) showed that the cells 
and fibrin gel mixture attached on the surface of the SIS scaffold. At day 7 (Figure 11a7-
c7/A7-C7) and day 30 (not shown), fluorescent images indicated that MCs and SDSCs 
were still evenly mixed with no detectable separation. 
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Figure 9 Microscopic images of SIS without cells (A: serosal side without fibrin gel; 
B: serosal side with fibrin gel; C: mucosal side without fibrin gel; D: mucosal side 
with fibrin gel) 
 
 
 
Figure 10 Microscopic images of SIS with fibrin gel and cells, showing the 
distribution of cells on SIS scaffold 
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Figure 11 Fluorescent microscopic images and microscopic images for the 
constructs at days 0 and 7 
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4.1.2 Histological and Immunohistochemical Evaluation 
The results of histological tests are shown in Figures 12-14. Safranin O staining and 
immunostaining showed that sulfated GAG (Figure 12A-C versus 12a-c) and collagen II 
(Figure 13A-C versus 13a-c) accumulated with time (day 30 versus day 7) in all three 
groups. At day 30, the co-culture of SDSCs and MCs yielded tissue constructs exhibiting 
more interspersed GAG (Figure 12C), collagen II (Figure 13C), and collagen I (Figure 
14C). The SDSC group yielded tissue constructs with more thick and dense expression of 
GAG (Figure 12B) and collagen II (Figure 13B) and less expression of collagen I (Figure 
14B) than the other groups. 
 
 
Figure 12 Safranin O staining to evaluate GAG product of MC (a, A), SDSC (b, B), 
and SDSC+MC (c, C) at day 7 (a, b, c) and day 30 (A, B, C) 
 
4.1.3 Quantitative Biochemical Assessment 
In order to understand the whole trend of cell number and that of GAG product to cell 
number ratio during the culture process, we adopt relative DNA amount (the ratio of 
DNA amount at day 7 or day 30 to that at day 0) and relative GAG amount (the ratio of 
GAG amount to DNA amount) as assessing indices. Figure 15 shows the changes in 
relative DNA amount. In the MC group, DNA amount decreased dramatically throughout 
the period; while in the SDSC group, although DNA amount decreased during the earlier  
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Figure 13 Immunostaining to evaluate collagen type II product of MC (a, A), SDSC 
(b, B), and SDSC+MC (c, C) at day 7 (a, b, c) and day 30 (A, B, C) 
 
 
Figure 14 Immunostaining to evaluate collagen type I product of MC (a, A), SDSC 
(b, B), and SDSC+MC (c, C) at day 7 (a, b, c) and day 30 (A, B, C) 
 
culture, DNA increased later from day 7 to day 30. Even in the earlier stage, the number 
of SDSCs decreased more slowly than that of MCs. The co-culture group was in the 
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middle of two control groups, decreasing all the time but slower than MCs only. In the 
MC group, the adjusted DNA ratio was 49.8 ± 4.2% at day 7 versus 31.9 ± 5.2% at day 
30 (P = 0.0003); in contrast, in the SM group, the adjusted DNA ratio was 59.2 ± 15.4% 
at day 7 versus 53.0 ± 10.6% at day 30 (P = 0.5201), while in the SDSC group, the 
adjusted DNA ratio was 72.0 ± 11.6% at day 7 versus 77.8 ± 16.6% at day 30 (P = 
0.5534). The data showed that the SDSC group had a stable DNA content at the highest 
level, indicating that SDSCs were able to maintain cell numbers when co-cultured with 
MCs. 
 
The comparison of relative GAG amount is shown as Figure 16. With incubation in 
chondrogenic medium, all groups exhibited an increase in chondrogenic index 
(GAG/DNA) over time. At days 0 or 7, there was no significant difference in 
chondrogenic index among the three groups. At day 30, however, the chondrogenic index 
increased dramatically in the SDSC group compared to that at day 7 (74.70 ± 5.33% 
versus 6.50 ± 0.99); the chondrogenic index in the SDSC group was almost 3.3-fold 
compared to the SM group and 5.7-fold compared to the MC group. Though the 
chondrogenic index was the lowest in the MC group, the MCs co-cultured with SDSCs 
exhibited a significantly increased chondrogenic index (22.74 ± 5.33 versus 13.00 ± 1.39).  
 
 
Figure 15 DNA ratio adjusted by DNA amount at day 0 (* = p <0.05; ** = p < 0.01; 
and *** = p < 0.001) 
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Figure 16 Ratio of GAG to DNA (* = p <0.05; ** = p < 0.01; and *** = p < 0.001) 
 
4.1.4 Messenger RNA Analysis 
Real time PCR was used to quantify the relative amount of meniscus markers or 
transcriptional factors in mRNA level. Collagen type I, type II, type X, aggrecan, and 
Sox9 were measured and the results were shown in Figures 17-20. Each mRNA was 
compared among different groups at three time points. 
 
For collagen type I, there were distinct trends for different groups (Figure 17). MCs had 
the highest mRNA level of collagen type I (Col I) for day 0, which decreased 
continuously to day 7 and then to day 30. For the SDSC group, the content of Col I 
mRNA increased by day 7 and then began to decreasing to day 30. The co-culture group 
behaved in a similar manner as the MC group, except that for each time point, the total 
amount of Col I mRNA was smaller than the latter group. 
 
There is a totally different result for collagen type II (Col II) (Figure 18). Compared to 
day 30, the SDSC group and co-culture group had a negligible amount of Col II mRNA 
for day 0 and day 7. Although the change in the MC group is small relative to the SDSC 
and co-culture groups, there existed an increase-to-decrease trend during the culture 
process. 
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Figure 17 Collagen type I gene expression using Taqman® real time PCR test and 
adjusted by 18S RNA 
 
 
Figure 18 Collagen type II gene expression using Taqman® real time PCR test and 
adjusted by 18S RNA 
 
Similar to Col II, aggrecan exhibited a continuously increasing tendency in mRNA level 
for the SDSC group and co-culture group (Figure 19). However, for the MC group, 
aggrecan mRNA still increased throughout the 30 days, without the turning point that Col 
II mRNA had. 
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Figure 19 Aggrecan gene expression using Taqman® real time PCR test and 
adjusted by 18S RNA 
 
Sox9 is a transcriptional factor, which can up-regulate the expression of COL2A1 and 
aggrecan genes. The level of Sox9 mRNA also increased throughout the culture period 
within each group (Figure 20). 
 
 
Figure 20 Sox9 gene expression using Taqman® real time PCR test and adjusted by 
18S RNA 
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We also examined Collagen type X (Col X) (not shown), which is a specific marker of 
hypertrophic chondroncytes, and is induced during osteoarthritis progression. We found 
that, on the transcription level, the MC group increased gradually, while the SDSC group 
increased first and then decreased, in contrast to the co-culture group, which decreased 
first and then increased. 
 
4.1.5 Mechanical Evaluation  
In order to evaluate the constructs more comprehensively, we measured the compressive 
modulus for each construct (n=8) at day 30. As shown in Figure 21, the MC group has 
the lowest compressive modulus (15.55±5.01 MPa), the SDSC group has the highest 
(35.18±24.16 MPa), and the co-culture group has an intermedial value and closer to the 
MC group (22.80±4.30MPa). We also found that the SDSC group has a much larger 
standard deviation than the MC group and co-culture group.  
 
Figure 21 Equilibrium modulus of tissue constructs from different groups after a 
30-day-incubation 
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4.2 Results from Part II 
4.2.1 Biochemical Assessment 
In this part, we first measured the GAG amount and DNA amount for a preliminary 
outcome, since DNA content could tell us the viability and proliferation of cells, and 
GAG product could suitably reflect the chondrogenic or meniscal differentiation. We 
found that some groups had no DNA or GAG detected; in this case, there might be of 
little usefulness if we adjusted the DNA amount by that of day 0 and GAG amount by 
that of corresponding DNA. Considering this, we directly make use of the absolute 
amount of DNA or GAG and graph them as in Figures 22 and 23, respectively. 
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Figure 22 DNA content 
O: Day 0 control;     B1: Bioreactor culture for 1 week; 
B3: Bioreactor culture for 3 weeks;   S3: Static culture for 3 weeks; 
BB6: Bioreactor culture both for earlier stage and later stage (3 weeks each); 
SB6: Static culture for earlier 3 weeks, bioreactor culture for later 3 weeks; 
BC6: Bioreactor culture for earlier 3 weeks, compressive loading for later 3 weeks; 
SC6: Static culture for earlier 3 weeks, compressive loading for later 3 weeks. 
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Figure 23 GAG content 
 
4.2.2 Histological Evaluation 
Similarly, histological evaluations were made to examine the expression of GAG and 
collagen types II and I. Unfortunately but consistent with biochemical tests, there was no 
GAG, collagen type II or I produced for all the 6-week samples (Figure 24 is shown on 
next page and for collagen type II only). From the microscopic images, we know that 
most cells were lost after the initial culture in bioreactors, and basically only the SIS 
structure remained. No GAG or collagen type II was produced during the culture period; 
some collagen type I can be seen for the control samples at day 0. 
 
4.2.3 Mechanical Measurement 
We measured both compressive and tensile strengths to examine the mechanical 
properties of our tissue engineered constructs, and for each, we calculated equilibrium 
modulus, Young’s modulus, and stiffness (Figures 25 and 26).  The tensile strengths are 
significantly higher than the compressive ones, and equilibrium moduli are higher than 
corresponding Young’s moduli. The relative magnitudes of stiffness are consistent with 
Young’s modulus for both compressive and tensile properties. Among different groups, 
samples undergoing compressive loading turned out to have higher compressive stiffness, 
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whereas those cultured in bioreactors during the earlier and/or later stage had higher 
tensile equilibrium modulus. The detailed numbers are not provided here. 
 
 
 
Figure 24 Immunostaining for collagen type II 
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Figure 25 Compressive modulus or stiffness 
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Figure 26 Tensile modulus or stiffness 
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CHAPTER 5 ANALYSIS AND DISCUSSION 
 
The goal of this study was to develop in vitro meniscus tissue constructs using a co-
culture technique with a tissue-specific stem cell on a clinically approved natural 
biomaterial. Our data showed that MCs, SDSCs, and co-culture of MCs and SDSCs were 
able to mix with fibrin gel and evenly adhere on SIS, suggesting good biocompatibility 
between cells and biomaterial. After the initial drop, the cell number of MCs on SIS 
continued to decrease with incubation time; this trend was reversed when MCs were 
combined with SDSCs. The addition of SDSCs could also dramatically increase 
chondrogenic differentiation of MC-based tissue constructs, resulting in the acquisition of 
higher equilibrium modulus. Our study indicates that functional menisci can be 
engineered in vitro with SDSCs and MCs co-cultured on SIS-based scaffolds in a serum-
free chondrogenic medium. 
 
5.1 Justification of SIS as Scaffold 
As an accellular ECM79, 120, SIS scaffold is composed of 80% to 90% collagen in the 
form of oriented fibers, contributing to longitudinal tensile properties, and contains 
glycosaminoglycans as well as entrapped growth factors, such as basic fibroblast growth 
factor, vascular endothelial cell growth factor, and TGF-β124, 125, 126. In this study, our 
SEM data showed that the seeded cells attached on the surface of SIS well and 
established a base for their interaction with the scaffold, which potentially allowed the 
delivery and receiving of signals for cell growth, proliferation and differentiation. 
Fluorescence images confirmed the biocompatibility of SIS and implied that SDSCs and 
MCs were compatible with each other. SIS is also a biodegradable biopolymer. SIS has 
been reported to be entirely resorbed three months after implantation in the bladder of 
dogs and replaced by deposition of a new host ECM through the body’s natural healing 
process, with successful replacement of the damaged urinary tissue 127 . Many 
experimental studies have demonstrated the feasibility of SIS in tissue engineering, such 
as for human bone marrow stem cells to proliferate128, for tissue engineering bladder 
from bone marrow stromal cells129, and for anterior cruciate ligament tissue engineering86. 
However, the degradation kinematics and communication between SIS and cultured cells 
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or host tissues are not yet completely understood, and further research is needed to fully 
understand the capacity of this multifaceted biological system. What is more, since SIS is 
a naturally derived material, batch-to-batch variations exist. Despite the shortcomings of 
SIS, it is still an ideal choice for the treatment of many joint injuries. 
 
5.2 Justification of Pre-treating and Seeding Method 
We found that the seeded cells were difficult to immobilize on the smooth and saturated 
SIS scaffold. However, after freeze-drying and re-saturating with PBS, most PBS in SIS 
can be easily resorbed by sterile gauze while maintaining SIS in hydrophilic condition. In 
this study, fibrin gel was applied by mixing with cells, which could be easily absorbed by 
half-dried SIS. As we know, fibrin is the basic framework on which the repair response 
of most tissues is initiated. In an in vitro culture system, meniscus fibrochondrocytes 
have been shown to be capable of extricating themselves from their surrounding matrix 
and migrating into a purified fibrin clot109. In vivo studies have also shown the efficacy of 
an exogenous fibrin clot to support a repair response in the avascular portion of the 
meniscus44, 130 . Therefore, fibrin can be considered a quintessential model for the 
matrices on which tissue-engineered menisci are created; it provides a deformable 
scaffold for even cell distribution, migration and orientation, and the ability to disappear 
over time123. One of the limiting factors in the use of fibrin, however, is the fragile nature 
of this scaffold. Therefore, the combined use with other clinically approved natural 
biopolymers (such as SIS) will complement the weakness of fibrin gel due to its lack of 
mechanical strength. 
 
Although the SIS preparation method includes processes such as acellularization, 
sterilization, and lyophilization, this scaffold still retains some active growth factors that 
can contribute to its biologic activity125, 131. As a xenogenic graft, host immunological 
response should always be of concern. Allman et al. has reported that porcine SIS elicits 
an immunological response restricted to the Th2 pathway, which is consistent with a 
remodeling reaction rather than rejection 132 . When surgically implanted, this 
biocompatible and biodegradable scaffold provides strength for the reinforcement of 
damaged or weakened soft tissues, and constitutes an alternative to autograft or allograft. 
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SIS promotes cell proliferation/differentiation, and induces the synthesis of a new tissue 
structurally and functionally similar to the original damaged tissue133.  
 
5.3 Justification and Validation of Co-culture Technique 
We showed that SIS is suitable for cell attachment and growth; however, different cells 
may behave differently on the surface of SIS. MCs are a kind of adult cell, and their 
viability throughout the culture process is not as good as the pluripotent SDSCs. The 
DNA ratio diagram implies that MCs’ death dominate for all 30 days, while although 
SDSCs die in earlier stage, they survive more and even proliferate to a higher DNA 
amount later. Due to the high viability and ability to proliferate, SDSCs are a potent cell 
source for meniscus regeneration. 
 
Like articular cartilage, the inner third of meniscus is under a predominantly compressive 
load and has poor healing potential. In some studies, the repair (meniscus) tissue was 
reported to be a cartilage-like tissue61, 134, 135. Also, chondrocytes have been successfully 
used as a cell source to engineer tissue constructs for the repair of a bucket-handle tear 
and longitudinal-horizontal lesion (avascular portion) of menisci 136 , 137 . Although 
meniscus and cartilage are two different tissues, the detailed knowledge already available 
for articular cartilage metabolism might be very helpful in developing future protocols for 
engineering avascular meniscus tissue. MSCs from bone marrow appear to have a high 
propensity for cartilage hypertrophy and bone formation138, 139 and therefore may not be 
ideal chondroprogenitors for the repair of meniscus. SDSCs are a promising stem cell for 
cartilage tissue engineering because they display greater chondrogenic and less 
osteogenic potential than MSCs derived from bone marrow or periosteum140. They were 
also proven to be superior to other sources of MSCs such as adipose tissue and muscle68, 
69. Furthermore, meniscus defect regeneration has been shown to alleviate through the 
migration, proliferation and differentiation of fibroblasts that originates, presumably, 
from the adjacent synovium and joint capsule83, 134.  
 
In this study, the co-culture of MCs and SDSCs was evaluated for chondrogenic 
differentiation capacity in a serum-free chondrogenic medium. Our data suggested that, 
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during the first seven days of incubation, cell number decreased in each group with the 
MC group decreasing the most and the SDSC group decreasing the least. This may be 
due to the change in culture conditions from serum-containing to serum-free medium, in 
which serum-deprivation would result in cell apoptosis141. In addition, monolayer culture 
favors cell proliferation while three-dimensional culture benefits cell differentiation. 
During day 7 and day 30, cell numbers continued to decrease in the MC group; in 
contrast, cell number started to increase in the SDSC group and although the difference 
was not statistically significant, the results suggested that SDSCs are more receptive to 
stimulation by TGF-β1 in maintaining and increasing cell number of pellets compared to 
MCs. Cell number in the SM group remained stable. Our data indicate that the co-culture 
with SDSCs contributes to the maintenance of cell number in MC-based tissue constructs.  
 
The co-culture design is of great importance in this study, and possibly in other meniscal 
regeneration. As mentioned before, SDSCs play a pivotal role in three aspects: (1) since 
MCs are limited, adoption of SDSCs can be a cell source for meniscal regeneration 
because of their high capacity in proliferation and differentiation; (2) the existence of 
SDSCs may increase the expression of collagen type II and aggrecan, which indicates 
that tissue engineered constructs under such conditions may be more like the avascular 
inner zone of meniscus; (3) the action of SDSCs is a potential reason for the down-
regulation of collagen type X during the whole culture period, which may contribute to 
the maintenance of healthy status for meniscus cells, rather than progressing into 
hypertrophy. On the other hand, MCs are equally important in the co-culture system 
because they can help direct SDSCs to differentiate into specially aimed tissue, based on 
the principle of interaction between adult cells and pluripotent cells70. 
 
5.4 Justification of Mechanical Measurements 
The functions of load transmission and shock absorption of meniscus require that the 
tissue itself should bear strong mechanical properties. Previous study142 provided detailed 
values of tensile and compressive moduli for different zones of meniscus, including 
surface, middle, and deep zones. Effective treatments for meniscal tears or defects must 
attempt to maintain the mechanical properties of native tissues, and mechanical 
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measurements are pivotal for judging the outcome of our study. There are many different 
models and corresponding assumptions to evaluate the mechanical behavior of articular 
cartilage or meniscus: elastic143, viscoelastic144, biphasic145 and triphasic146. Based on the 
assumption of elasticity, the one-step measurement is sufficient to calculate the Young’s 
modulus and stiffness. Although they are both elastic properties and can be measured in 
one step, Young’s modulus is independent of the geometrical properties, while stiffness is 
related to the cross-sectional area and the length of constructs from our study. Therefore, 
we measured strain, stress, cross-sectional area and length of constructs, and calculated 
both. However, this is rather rough for meniscal tissue, since it is much different from 
elastic materials. Another popular model is the biphasic one, and in this case, equilibrium 
modulus is the key parameter, since it is not linear throughout the measurement period. In 
this study, we applied four or five consecutive strains and allowed sufficient relaxation 
between every two measurement points. During the relaxation process, there is fluid flow 
within the constructs; at the equilibrium points after relaxation, there is no fluid flow in 
the constructs. Equilibrium modulus reflects more genuine situation than Young’s 
modulus for biphasic materials, and it is the basic property we measured in our study. In 
the second part of this study, to evaluate the constructs from different view points, we 
measured Young’s modulus and stiffness apart from equilibrium modulus. 
 
5.5 Discussion about Biochemical Results from Part I 
Histological, immunohistochemical, biochemical, and real time PCR tests gave us 
consistent results. We can describe overall trends for the changes in density or amount of 
GAG, Col I and Col II. GAG and Col II accumulated over time for all three groups, while 
Col I results were a little more complicated. From immunohistochemical tests, the MC 
group changed little and the SDSC and co-culture groups grew denser from day 7 to day 
30. From real time PCR tests, the MC group and co-culture group decreased throughout 
the culture period, while the SDSC group first increased, then decreased. Since GAG is 
just one chemical component of aggrecan, the biochemical and histological results can 
keep certain, but not total, consistence with real time PCR analysis. 
 
 50
The differences between collagen types I and II may be explained by the complex 
structure of meniscus and the differential capacity of SDSCs. Collagen type I accounts 
for over 90% of the total collagen content in meniscus, much more than collagen type II20.  
Due to the gradual death of meniscal cells on SIS, Collagen type I decreased 
correspondingly in the MC group. While under culture in chondrogenic medium, which is 
defined purposely to induce cartilage formation, the signals for collagen type II 
expression may be abundant and therefore increase the content of collagen type II. But 
for the SDSC group and co-culture group, because of the existence of SDSCs, both 
collagen types I and II accumulated under this specially defined medium. The expression 
of aggrecan is similar to collagen type II, increasing along with culture time within 30 
days. Previous reports indicated that the peripheral two-thirds of the meniscus solely 
consists of collagen type I, whereas collagen type II comprises a significant portion of the 
fibrillar collagen in the inner meniscus21. Moreover, aggrecan aggregate content is higher 
in the inner and middle part than in the peripheral part of the meniscus95. Our results 
indicate that the existence of SDSCs can help increase of the collagen type II and 
aggrecan content in meniscus, which makes the tissue engineered constructs more like 
the inner part of natural and host tissue, which is the avascular zone that is difficult to 
treat. 
 
Concerning the differences between real time PCR analysis and other results, we 
speculate that it is because they are evaluated from different levels. Real time PCR is at 
the mRNA level and other testing is at the protein level or equivalent, where change 
would lag behind those in mRNA. Therefore, in the SDSC group, although the amount 
collagen type I mRNA decreased from day 7 to day 30, we saw an accumulation of 
collagen type I from immunohistochemical images due to the increase in collagen type I 
mRNA during the earlier stage. The same is true in the MC group for collagen type II. 
 
Collagen type X is a specific marker of hypertrophic chondroncytes, and occur 
exclusively in hypertrophic cartilage of the growth plate, which is an essential feature of 
cartilage degradation147, 148. There exists no collagen type X in normal meniscus, as 
reported by Eyre and Wu20 and by McDevitt and Webber6. The increase of collagen type 
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X mRNA for MCs in our study may indicate that under our defined chondrogenic 
medium, normal meniscus cells may differentiate into hypertrophy and initiate 
osteoarthritis, in a manner similar to the pathology from hypertrophic chondrocytes. 
Fortunately, the existence of SDSCs may inhibit the transcription and expression of 
collagen type X, maintaining the health of the construct, which is another potentially 
important effect of SDSCs in the co-culture system. However, hypertrophy has not been 
confirmed, and the underlying mechanism of inhibition needs to be clarified. 
 
The transcriptional factor Sox9 remains at high levels in fully differentiated chondrocytes, 
in a remarkably similar expression pattern to Col2a1149. A chondroctye-specific enhancer 
in the gene for collagen type II is a direct target for Sox9, and consequently it plays a 
major role in chondrogenesis150, 151. In our study, the increase of Sox9 mRNA and further 
Sox9 protein will be beneficial to the expression of collagen type II. This is also 
consistent with the increasing tendency of collagen type II as stated before. Even for the 
MCs alone, Sox9 and collagen type II accumulate during the culture period and under our 
defined medium. 
 
5.6 Discussion about Biomechanical Results from Part I 
As for biomechanical measurement, the co-culture group has similar results to the MC 
group compared to the SDSC group. This is interesting and exciting because the 
meniscus tissue, which naturally consists of meniscus cells as used in the MC group, is 
the very goal we want to reach. Furthermore, the compressive modulus of SDSCs alone 
vary a lot more than MCs and co-culture constructs, which may indicate that the 
existence of MCs is favorable to keep the compressive modulus in a certain range, rather 
than fluctuating severely. However, previous studies reported that the compressive 
aggregate modulus of human menisci is 0.22 MPa152. This difference may be explained 
by the different hosts, the differences between in vivo tissues and in vitro constructs, and 
the contribution of SIS. Notwithstanding, the result that the compressive modulus of the 
MC group is lower than SDSCs, a kind of pluripotent cells able to differentiate into 
chondrocytes under these conditions, is consistent with previous data142, 153. 
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Another important property of meniscus, tensile strength, was not measured in this pilot 
study. We did not evaluate this is that in the first part of the study, because we were 
focused on validating the use of SIS and the biochemical composition of engineered 
constructs. We know that biochemical composition could determine the functional 
properties of tissues, so we chose to study the biochemical components first. At the same 
time, one of the important mechanical features, compressive strength, were tested to 
confirm the result of biochemical assessment and was compared between groups to 
obtain useful information for further comprehensive studies. 
 
5.7 Trouble Shooting for the Biochemical Failure of Part II 
Unfortunately, although we tried several times in the second part of this study in which 
we used bioreactor incubation and compressive stimulation, we failed to produce any 
positive data showing the strengths of either bioreactor incubation or compressive 
stimulation. Instead, we found that the amount of GAG produced within 3 weeks, even 
within 6 weeks, decreased rapidly relative to the starting point, which is shown in Figure 
13. Also, we did Safrinin O staining and immunostaining for collagen types I and II; 
unfortunately, they did not work as we expected. To better understand these and to avoid 
the problems in future studies, we analyzed all the factors involved in the second 
experiment, and made comparisons with the first part to support our analysis. 
 
5.7.1 Cells 
The first component we considered was the cells, including MCs and SDSCs. We noticed 
that the cells used in the two study parts were harvested from different pigs and at 
different times. The pigs were acquired from the same slaughterhouse, where they were 
raised routinely. The MC harvest procedures were the same as described in the Methods 
section; after cell harvest, MCs of passage 1 were stored for use in both experiments. 
While, SDSCs underwent different treatments: for part I, SDSCs were negatively isolated 
using Dynabeads® M-450 CD14 and a monoclonal antibody specific for macrophages for 
1 h at 4°C on an x-y-z shaker; for part II, SDSCs were stored for later use without this 
treatment. This is one possible reason for the different outcomes between the two 
experiments. SDSCs without negative isolation contained macrophages and fibroblasts123, 
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154, 155 which may contribute to inflammation and tissue injury as proposed by Glaros et 
al.156. We suspect that macrophages which were not negatively isolated in the second 
experiment, probably destroyed the normal metabolism of MCs and/or SDSCs. Thus, 
even if these cells successfully seeded on the scaffolds, the cells might die quickly or may 
not excrete matrix proteins as usual. One corresponding suggestion for future research is 
that SDSCs be stored and used only after negative isolation using Dynabeads® M-450 
CD14 and a monoclonal antibody specific for macrophages. 
 
5.7.2 Scaffold 
Another important element in our study is the scaffold SIS and related treatments. After 
examination, we found that the scaffolds used in the two experiments were exactly the 
same, and they were prepared following the identical protocol as described before. Indeed, 
we observed that the two sides of SIS are different, and even further, the SIS used in Part 
I possibly had two layers (Figure 29). We did try to split the SIS into two separate layers 
and to seed cells on each, in order to understand better growth, proliferation, and 
differentiation on the scaffold. We unfortunately found that each individual layer of SIS 
was too thin to hold the cell suspension when we seeded the cells as described before. 
Therefore, we treated the scaffold following exactly the same procedure as in Part I. 
Moreover, the seeding method with fibrin glue did not change at all, which can further 
exclude the possibility that the scaffold SIS or related treatments brought about the 
failure of Part II, which aimed to optimize the culture conditions using bioreactors and 
compressive loading. 
    
Figure 27 SIS before freeze-drying 
Left: before split Right: after split  
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5.7.3 Medium and Growth Factors 
Similarly, we examined the chemical factors of the chondrogenic medium we used during 
incubation. We used the same high-glucose DMEM together with proline, 
dexamethasone, ascorbic acid 2-phosphate, PS, and ITSTM Premix, as well as TGF-β1 
and IGF-I. All chemicals were newly purchased and prepared, with the exception of the 
growth factor TGF-β1, which was prepared two years ago, stored at -80˚C before use, 
and used in both studies. The concentrations of each chemical agent were kept consistent 
in our studies. One point to be mentioned is that in Part II, we filtered the medium with 
the chemicals to avoid contamination; we used a 22-μm nylon filter. We do not think this 
additional treatment would remove the chemicals and growth factors before incubation 
for cell-hybrid scaffold constructs. This supposition can be supported by the relationship 
between Molecular Weight Cut-Off (MWCO) of filters and the molecular size of the 
chemicals involved. Tables 3 and 4 specify the molecular weight of chemicals in use and 
the relationship between MWCO and the diameter of membranes, respectively. 
 
Table 3 Chemicals and corresponding molecular weights 
Chemical Molecular weight  Chemical Molecular weight 
TGF-β1 25,000  Dexamethasone 392 
IGF-I 7649  ITSTM Premix  
Proline 115  Insulin 5808 
Penicillin 388  Transferrin ~80,000 
Streptomycin 582  Sodium selenite 173 
Ascorbic acid 2-
phosphate 
380    
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Table 4 Molecular weight cut-off (MWCO) and membrane diameter 
MWCO/Da Diameter/nm 
300,300 140 
200,100 55 
5,050 30 
3,030 22 
2,020 18 
1,010 15 
 
 
5.7.4 Hypoxia Incubation 
Concerning the culture conditions, we found that one important factor was changed 
between experiments. In Part I, we cultured the constructs in a hypoxic environment 
while in Part II, we incubated all bioreactors, static plates, and compression-loaded plates 
under normal oxygen concentration (20% O2 versus 5% O2). This change might have 
given rise to the completely different expressions of proteins. Adesida et al. 157 
investigated the potential of human meniscus cells to produce matrix in three-
dimensional cell aggregate cultures with a chondrogenic medium at low (5%) and normal 
(20%) oxygen tension. The expression of type II collagen was greatly increased (400-fold) 
by culture in 5% oxygen. The gene expression of matrix-associated proteoglycans 
(biglycan and fibromodulin) was also increased by hypoxia. They concluded that, after 
expansion in monolayer, MCs could respond to low oxygen tension during aggregate 
cultures. The same group found that human meniscus cells expressed hypoxia inducible 
factor-1alpha and increased Sox9 in response to low oxygen tension in cell aggregate 
culture. They revealed that inner meniscus cells were less responsive to 5% oxygen 
tension than were outer meniscus cells, and they were both more sensitive than articular 
chondrocytes from a similar joint. These results suggested that the vasculature and 
greater oxygen tension in the outer meniscus might help to suppress cartilage-like matrix 
formation158. 
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5.7.5 Rotation and Compression 
The most obvious difference in treatment between the two parts is that in Part I, we 
utilized complete static culture, and in Part II, we used rotating bioreactors and 
compressive loading, both of which would generate significant physical forces during 
incubation. Although many studies have been done with rotating bioreactors or 
compressive loading117, 159, 160, we suspect that the combined use of SIS and fibrin glue in 
our study might have caused the problems. The structure of SIS is much more compact 
than other synthetic materials that have been used with fibrin glue in cell culture and 
tissue engineering with PGA being an example161. The cell-fibrin hybrid cannot migrate 
into the scaffold fully, thus there is non-homogeneity throughout the disk. This can also 
be observed and demonstrated in our microscopic images of day 0 samples. For static 
culture, this may not affect cell growth, proliferation and differentiation, only if the cells 
are retained within the fibrin glue; under the shear force of the bioreactor rotating, the 
concentrated fibrin glue may degrade much more quickly than normal, releasing the cells 
into culture medium, which would be changed every 3 days. Although there are no direct 
studies that show the degradation kinetics of fibrin glue in a shear environment, we did 
observe that there was suspended substance in culture medium, especially in that of 1 day 
after placing the cell-glue-scaffold hybrid in bioreactors. We precluded the reason of 
contamination for this phenomenon, since we paid close attention when executing the 
experiments and the medium turned clear after the medium change. Fast degradation of 
fibrin glue under rotating shear would be an influential factor for the cell loss in our study. 
 
Applying different forces but similarly, the compressive loading would possibly 
accelerate gel degradation in our study. Presumably, this kind of action would not 
significantly degrade the gel in medium, since the constructs, including the gel on them, 
are statically placed in wells. However, Kang et al.162 studied the elasticity of fibrin gels 
and explained their nonlinear response. They found that the ratio of normal stress to shear 
stress is one parameter that distinguishes semiflexible and rigid filament models, and is 
also a factor affecting the elasticity of fibrin glue. Moreover, the non-homogeneous 
distribution of fibrin gels in SIS would further contribute to quick degradation of the glue, 
resulting in the loss of cells within the glue. This effect is similar to that of bioreactor 
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rotation: they both produce physical forces onto the constructs and specifically on the 
fibrin glue; the non-homogeneous distribution of gels may contribute to gel degradation 
in both cases. 
 
5.8 Discussion about Biomechanical Results from Part II 
Compared to natural meniscal tissues, the compressive or tensile strengths are much 
lower for the tissue engineered constructs in this study 错误！未定义书签。 . This relative 
weakness might be attributed to the scaffold SIS, the major component of our constructs, 
which were porous, and the cells, which did not penetrate throughout the scaffold 
soundly. As shown in the histological images, the inner structure of SIS was rather loose, 
and possibly contributed to the weak mechanical properties. Meanwhile, common 
features were found between the natural tissues and our engineered constructs: tensile 
strengths were significant higher than compressive ones. This is solidly supported by the 
data from previous studies 错误！未定义书签。, and provides a potential method to better engineer 
the meniscal constructs in vitro, if the problem of cell loss can be resolved. 
 
Young's modulus is a measure of the stiffness of an isotropic elastic material. It is also 
known as the Young modulus, modulus of elasticity, elastic modulus (though Young's 
modulus is actually one of several elastic moduli such as the bulk modulus and the shear 
modulus) or tensile modulus. It is defined as the ratio of the uniaxial stress over the 
uniaxial strain in the range of stress in which Hooke's Law holds. The stiffness is a 
measure of the resistance offered by an elastic body to deformation (bending, stretching 
or compression). Theoretically, the relative magnitude of stiffness is to some degree 
consistent with that of Young’s modulus, and the formula for their relationship is 
 
where 
k is the stiffness, 
A is the cross-sectional area,  
E is the Young's modulus,  
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L is the length of the element.  
This relationship was qualitatively confirmed by our data. 
 
Fox et al. studied the feasibility of using fibroblast-like synoviocytes to engineer 
meniscal-like fibrocartilage under dynamic compressive loads117. However, their applied 
biomechanical stimulus did not appear to induce fibrochondrogenesis in any treatment 
group on the scaffolds they used. Considering the fact that fibrocartilaginous tissues 
experience significant tensile stresses in their normal mechanical environment, 
Vanderploeg and co-workers118 investigated mechanical tension as a means to modulate 
matrix synthesis and cytoskeletal organization in bovine articular chondrocytes and 
meniscal fibrochondrocytes (MFCs). Chen et al.119 found differences in gene expression 
between anulus fibrosus and nucleus pulposus cells following static compression for the 
matrix proteins studied. These conflicting studies needed to be clarified with confirmative 
data. Our studies showed that compressive loading may increase the compressive 
stiffness or Young’s modulus, and bioreactor rotation is a possible cause for the increase 
in tensile equilibrium modulus. Lack of cell growth, proliferation, and differentiation for 
the constructs, there are no proofs to demonstrate that these changes in mechanical 
properties are due to the biochemical composition of the constructs. On the other hand, 
the results imply that either compressive loading or bioreactor rotation might change the 
mechanical properties of the scaffold itself, which were kept in medium. 
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CHAPTER 6 CONCLUSIONS AND RECOMMENDATIONS 
 
6.1 Conclusions 
In this study, an innovative tissue engineering method was attempted to reconstruct 
meniscus-like tissues in vitro. SIS, which demonstrated good cell attachment and 
viability, was tested to be a promising scaffold material for in vitro tissue engineering. Its 
porous structure potentially provides plenty of room for cell growth and proliferation, and 
its natural biocompatibility theoretically allows clinical and in vivo trials in future studies. 
Also, SIS itself may contribute to the mechanical properties of the constructs engineered; 
apart from the chemical ingredients it contains, it evolves into the constructs. 
 
Co-culture of MCs and SDSCs proved a successful way to tissue engineer meniscal 
constructs in vitro, especially for the inner avascular region. SDSCs potentially act in 
three main aspects: (1) to help solve the problem of limited cell source for meniscal 
regeneration because of their high capacity in proliferation and differentiation; (2) to 
increase the expression of collagen type II and aggrecan, which indicates that tissue 
engineered constructs under such conditions may be more like the avascular inner zone of 
meniscus, for which few therapy methods exist; (3) to down-regulate the expression of 
collagen type X during the whole culture period, which may contribute to the 
maintenance of health for MCs, rather than progressing into hypertrophy. On the other 
side, MCs are equally very important in the co-culture system because they can help to 
direct SDSCs to differentiate into special meniscal tissue. 
 
The second part of this study is a preliminary study for further application of co-culture 
technique with MCs and SDSCs on SIS. Although it failed to produce meniscal 
constructs with the expected composition and properties, we analyzed carefully and 
attempted many explanations, which would be important clues for future studies. After 
comprehensive scrutiny, there were several possible reasons for the unexpected results. 
The SDSCs without negative isolation before use could be an important cause, since they 
contained macrophages that may play a detrimental role in meniscal growth and 
differentiation. The second component, scaffold SIS together with fibrin gel, distributed 
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in a non-homogeneous manner throughout the scaffold; this might accelerate the 
degradation of fibrin gels and the loss of cells as no meniscal matrix was produced. As to 
culture conditions, normal oxygen concentration rather than hypoxia in this part may also 
suppress matrix formation, which is the most likely reason for the relative low matrix 
content for the static culture samples after three weeks. The final and most obvious 
factors, bioreactor rotation and compressive loading, would be the physical reasons for 
the cell loss and lack of final matrix in these cell-fibrin-SIS hybrid constructs, compared 
to the positive results from the first part of this study. 
 
Finally, mechanical tests implied that tensile strengths of developed constructs were 
higher than compressive ones, and this is consistent with natural meniscus. Stiffness of 
the constructs was relatively proportional to Young’s modulus, and also determined by 
the geometrical properties of constructs, as we calculated. The differences between 
groups in compressive stiffness or tensile equilibrium modulus might be caused by 
physical conditions, such as compressive loading or bioreactor rotation, since no direct 
biological and chemical data from this study could support the differences in mechanical 
properties. 
 
6.2 Recommendations 
SIS has been suggested as a good biomaterial for meniscal tissue engineering in vitro. 
However, the degradation kinematics of SIS and communication between SIS and cells 
are not yet fully understood. A good and full understanding of SIS is of great help for the 
clinic use of SIS, and deserves further research. Similarly, the kinetics of fibrin gel 
degradation needs further clarification, especially for its use in such cell-gel-scaffold 
hybrid cultured in a rotating bioreactor or under compressive loading. 
 
Negative isolation may be critical for SDSCs and their role in the co-culture system for in 
vitro meniscal reconstruction. It is suggested that further studies negatively isolate the 
SDSCs before store and use. At the same time, new seeding method with higher 
efficiency should be attempted to generate a homogeneous distribution of cells 
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throughout the whole scaffold. This is very important to meniscal construct engineering 
for clinic use, especially for the inner “white zone” of menisci. 
 
As for culture conditions, hypoxia is recommended for in vitro functional meniscal tissue 
engineering. Hypoxia is likely to favor the matrix formation of cartilage or meniscus 
based on literature and our previous studies. Bioreactor culture and compressive loading 
can be further studied to optimize the culture conditions for meniscal reconstruction. 
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